In Vitro Fungicidal Activities of Voriconazole, Itraconazole, and Amphotericin B against Opportunistic Moniliaceous and Dematiaceous Fungi
Top Cited Papers
- 1 March 2001
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 39 (3) , 954-958
- https://doi.org/10.1128/jcm.39.3.954-958.2001
Abstract
The NCCLS proposed standard M38-P describes standard parameters for testing the fungistatic antifungal activities (MICs) of established agents against filamentous fungi (molds); however, standard conditions are not available for testing their fungicidal activities (minimum fungicidal or lethal concentrations [MFCs]). This study evaluated the in vitro fungistatic and fungicidal activities of voriconazole, itraconazole, and amphotericin B against 260 common and emerging molds (174 Aspergillus sp. isolates [five species], 23 Fusarium sp. isolates [three species], 6 Paecilomyces lilacinus isolates, 6 Rhizopus arrhizus isolates, 23 Scedosporium sp. isolates, 23 dematiaceous fungi, and 5 Trichoderma longibrachiatum isolates). MICs were determined by following the NCCLS M38-P broth microdilution method. MFCs were the lowest drug dilutions that resulted in fewer than three colonies. Voriconazole showed similar or better fungicidal activity (MFC at which 90% of isolates tested are killed [MFC 90 ], 1 to 2 μg/ml) than the reference agents for Aspergillus spp. with the exception of Aspergillus terreus (MFC 90 of voriconazole and amphotericin B, >8 μg/ml). The voriconazole geometric mean (G mean) MFC for Scedosporium apiospermum was lower (2.52 μg/ml) than those of the other two agents (5.75 to 7.5 μg/ml). In contrast, amphotericin B and itraconazole G mean MFCs for R. arrhizus were 2.1 to 2.2 μg/ml, but that for voriconazole was >8 μg/ml. Little or no fungicidal activity was shown for Fusarium spp. (2 to >8 μg/ml) and Scedosporium prolificans (>8 μg/ml) by the three agents, but voriconazole had some activity against P. lilacinus and T. longibrachiatum (G mean MFCs, 1.8 and 4 μg/ml, respectively). The fungicidal activity of the three agents was similar (G mean MFC, 1.83 to 2.36 μg/ml) for the dematiaceous fungi with the exception of the azole MFCs (>8 μg/ml) for some Bipolaris spicifera and Dactylaria constricta var. gallopava . These data extend and corroborate the available fungicidal results for the three agents. The role of the MFC as a predictor of clinical outcome needs to be established in clinical trials by following standardized testing conditions for determination of these in vitro values.Keywords
This publication has 47 references indexed in Scilit:
- In Vitro Activities of Voriconazole, Itraconazole, and Amphotericin B against Blastomyces dermatitidis , Coccidioides immitis , and Histoplasma capsulatumAntimicrobial Agents and Chemotherapy, 2000
- Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermumJournal of Antimicrobial Chemotherapy, 1999
- In vitro efficacy and fungicidal activity of voriconazole againstAspergillus andFusarium speciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- In vitroactivity of voriconazole against selected fungiMedical Mycology, 1998
- Deep Infections Caused by Scedosporium prolificans: A Report on 16 Cases in Spain and a Review of the LiteratureMedicine, 1997
- Infections Due to Dematiaceous Fungi in Organ Transplant Recipients: Case Report and ReviewClinical Infectious Diseases, 1997
- Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungiAntimicrobial Agents and Chemotherapy, 1995
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- The Emerging Role of Fusarium Infections in Patients with CancerMedicine, 1988
- Disseminated Aspergillus ustus Infection Following Cardiac SurgeryAmerican Journal of Clinical Pathology, 1983